A CLUSTER-RANDOMIZED TRIAL OF A BEHAVIORAL INTERVENTION TO INCORPORATE A TREAT-TO-TARGET APPROACH IN THE CLINICAL CARE OF RHEUMATOID ARTHRITIS PATIENTS

被引：1
|
作者：
Harrold, L. R. [1 ]
Reed, G. W. [1 ,2 ]
Harrington, J. T. [3 ]
Barr, C. J. [2 ]
Saunders, K. C. [2 ]
Gibofsky, A. [4 ]
Greenberg, J. D. [2 ,5 ]
John, A. [6 ]
Devenport, J. [6 ]
Kremer, J. M. [7 ,8 ]
机构：
[1] Univ Massachusetts, Sch Med, Worcester, MA USA
[2] Corrona LLC, Southborough, MA USA
[3] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA
[4] Hosp Special Surg, New York, NY 10021 USA
[5] NYU Sch Med, New York, NY USA
[6] Genentech Inc, San Francisco, CA 94080 USA
[7] Albany Med Coll, Albany, NY 12208 USA
[8] Ctr Rheumatol, Albany, NY USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.6305
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0286
引用
收藏
页码：988 / 990
页数：2
相关论文
共 50 条
  • [21] Rheumatoid Arthritis Disease Activity Assessment Frequencies in Clinical Practices Do Not Support Treat-to-Target Care
    Sikes, David
    Bower, James
    Johnson, Drew
    Harrington, J. Timothy
    Khalil, Rafia
    LaCour, Edmund
    Naarendorp, Michael
    Norton, Hillary
    Thomas, Kathleen
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [22] Case management of arthritis patients in primary care: A cluster-randomized controlled trial
    Rosemann, Thomas
    Joos, Stefanie
    Laux, Gunter
    Gensichen, Jochen
    Szecsenyi, Joachim
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (08): : 1390 - 1397
  • [23] CLUSTER-RANDOMIZED PRAGMATIC CLINICAL TRIAL EVALUATING THE POTENTIAL BENEFIT OF A TIGHT-CONTROL AND TREAT-TO-TARGET STRATEGY IN AXIAL SPONDYLOARTHRITIS: THE RESULTS OF THE TICOSPA TRIAL.
    Molto, A.
    Lopez-Medina, C.
    Van den Bosch, F.
    Boonen, A.
    Webers, C.
    Dernis, E.
    Van Gaalen, F. A.
    Soubrier, M.
    Claudepierre, P.
    Baillet, A.
    Starmans-Kool, M.
    Van der Heijde, D.
    Dougados, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 413 - 413
  • [24] PREDICTORS OF CLINICAL AND IMAGING REMISSION IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS MANAGED WITH A TREAT-TO-TARGET APPROACH: RESULTS FROM AN EARLY ARTHRITIS CLINIC
    Horton, Sarah C.
    Tan, Ai Lyn
    Wakefield, Richard J.
    Freeston, Jane E.
    Buch, Maya H.
    Emery, Paul
    RHEUMATOLOGY, 2015, 54 : 76 - 76
  • [25] Obstacles to the implementation of the treat-to-target strategy for rheumatoid arthritis in clinical practice in Japan
    Kaneko, Yuko
    Koike, Takao
    Oda, Hiromi
    Yamamoto, Kazuhiko
    Miyasaka, Nobuyuki
    Harigai, Masayoshi
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Tanaka, Yoshiya
    Takeuchi, Tsutomu
    MODERN RHEUMATOLOGY, 2015, 25 (01) : 43 - 49
  • [26] The Value of Adding MRI to a Clinical Treat-to-Target Strategy in Rheumatoid Arthritis Patients in Clinical Remission: Clinical and Radiographic Outcomes from the Imagine-RA Randomized Controlled Trial
    Moller-Bisgaard, Signe
    Horslev-Petersen, Kim
    Ejbjerg, Bo Jannik
    Hetland, Merete Lund
    Glinatsi, Daniel
    Ornbjerg, Lykke
    Moller, Jakob M.
    Boesen, Mikael
    Christensen, Robin
    Stengaard-Pedersen, Kristian
    Madsen, Ole Rintek
    Jensen, Bente
    Villadsen, Jan Alexander
    Hauge, Ellen-Margrethe
    Bennett, Philip
    Hendricks, Oliver
    Asmussen, Karsten
    Kowalski, Marcin Ryszard
    Lindegaard, Hanne
    Nielsen, Sabrina Mai
    Bliddal, Henning
    Krogh, Niels Steen
    Ellingsen, Torkell
    Nielsen, Agente
    Balding, Lone
    Jurik, Anne Grethe
    Thomsen, Henrik S.
    Ostergaard, Mikkel
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [27] Treat-to-target concept implementation for evaluating rheumatoid arthritis patients in daily practice
    Gazitt, Tal
    Oren, Shirley
    Reitblat, Tatiana
    Lidar, Merav
    Gurman, Alexandra Balbir
    Rosner, Itzhak
    Halabe, Nimer
    Feld, Joy
    Kassem, Sameer
    Lavi, Idit
    Elkayam, Ori
    Zisman, Devy
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2019, 6 (03) : 136 - 141
  • [28] Is there a reduction in hip destruction under a treat-to-target strategy in patients with rheumatoid arthritis?
    Tsushima, Hidetoshi
    Takahide, Sakuragi
    Akasaki, Yukio
    Fujiwara, Toshifumi
    Hara, Daisuke
    Ikemura, Satoshi
    Sakuraba, Kouji
    Kamura, Satoshi
    Miyahara, Hisaaki
    Yamada, Hisakata
    Fukushi, Jun-ichi
    Nakashima, Yasuharu
    MODERN RHEUMATOLOGY, 2024, 34 (02) : 334 - 339
  • [29] INITIAL EVIDENCE FOR THE NEED OF A DUAL TREAT-TO-TARGET STRATEGY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Oppenauer, Claudia
    Durechova, Martina
    Zauner, Michael
    Posch, Martin
    Urach, Susanne
    Machold, Klaus
    Aletaha, Daniel
    Ferreira, Ricardo
    Stamm, Tanja
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1118 - 1119
  • [30] 10 YEARS OF TREAT-TO-TARGET THERAPY IN RHEUMATOID ARTHRITIS PATIENTS (THE BEST STUDY): CLINICAL AND RADIOGRAPHIC OUTCOMES
    Markusse, I.
    Dirven, L.
    vd Broek, M.
    Akdemir, G.
    Goekoop-Ruiterman, Y.
    Han, H.
    Kerstens, P.
    Lems, W.
    Huizinga, T.
    Allaart, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 272 - 273
12345